Activity Overview
This online, on-demand virtual symposium brings together experts in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), an increasingly recognized inflammatory demyelinating disorder with distinct clinical, radiographic, and immunologic features. In this educational program, these experts share data and expert commentary drawn from years of treating patients with MOGAD. Faculty will focus on when to suspect MOGAD, how to interpret clinical presentations across age groups, and the optimal use and limitations of serum MOG-IgG testing, including assay selection and result interpretation. This educational activity is an archive of the live virtual symposium held on February 6, 2026.
Target Audience
This educational activity is directed toward neurologists, specialty neurologists, nurses, specialty nurse practitioners, and specialty physician assistants involved in the care of patients with neurological disease.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the burden of disease of MOGAD
- Identify the differential diagnosis for MOGAD
- Implement diagnostic criteria to differentiate MOGAD from other similar disorders
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here